SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001144204-12-066990
Filing Date
2012-12-07
Accepted
2012-12-07 16:31:50
Documents
1
Period of Report
2012-11-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT v329815_3.html 3  
1 OWNERSHIP DOCUMENT v329815_3.xml 3 3678
  Complete submission text file 0001144204-12-066990.txt   5564
Mailing Address 787 SEVENTH AVENUE NEW YORK NY 10019
Business Address 787 SEVENTH AVENUE NEW YORK NY 10019 (212) 554-4484
TG THERAPEUTICS, INC. (Issuer) CIK: 0001001316 (see all company filings)

IRS No.: 363898269 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958
Business Address 3 AVENUE DES TROPIQUES LES ULIS COURTABOEUF I0 91958 33 6 33554531
LFB Biotechnologies S.A.S.U. (Reporting) CIK: 0001377942 (see all company filings)

State of Incorp.: I0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-32639 | Film No.: 121250298